1. ScholarBank@NUS

Liang Xu

rp10532

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Liang Xu
(not current staff)
Variants
Xu Liang
 
Main Affiliation
 
Faculty
 
Email
csixl@nus.edu.sg
 

Publications

Refined By:
Department:  DEAN'S OFFICE (DUKE-NUS MEDICAL SCHOOL)

Results 1-6 of 6 (Search time: 0.006 seconds).

Issue DateTitleAuthor(s)
12018Functional genome-wide screening identifies targets and pathways sensitizing pancreatic cancer cells to dasatinibChien W. ; Sudo M. ; Ding L.-W. ; Sun Q.-Y. ; Wuensche P.; Lee K.L. ; Hattori N.; Garg M. ; Xu L. ; Zheng Y.; Gery S.; Wongphayak S. ; Yang H. ; Baloglu E.; Shacham S.; Kauffman M.; Mori S. ; Phillip Koeffler H.
22020Multiple myeloma: Combination therapy of BET proteolysis targeting chimeric molecule with CDK9 inhibitorLim, S.-L.; Xu, L. ; Han, B.-C.; Shyamsunder, P. ; Chng, W.-J. ; Phillip Koeffler, H. 
32017Mutational profiling of acute lymphoblastic leukemia with testicular relapseDing, L.-W ; Sun, Q.-Y ; Mayakonda, A ; Tan, K.-T ; Chien, W ; Lin, D.-C ; Jiang, Y.-Y ; Xu, L ; Garg, M ; Lao, Z.-T ; Lill, M.; Yang, H ; Yeoh, A.E.J ; Koeffler, H.P 
42018Profiling the B/T cell receptor repertoire of lymphocyte derived cell lines 11 Medical and Health Sciences 1107 ImmunologyTan, K.-T ; Ding, L.-W ; Sun, Q.-Y ; Lao, Z.-T ; Chien, W ; Ren, X; Xiao, J.-F ; Loh, X.Y ; Xu, L ; Lill, M; Mayakonda, A ; Lin, D.-C; Yang, H ; Koeffler, H.P 
52019Proteolysis targeting chimeric molecules as therapy for multiple myeloma: Efficacy, biomarker and drug combinationsLim, S.L.; Damnernsawad, A.; Shyamsunder, P. ; Chng, W.J. ; Han, B.C.; Xu, L. ; Pan, J.; Pravin, D.P. ; Alkan, S.; Tyner, J.W.; Koeffler, H.P. 
615-Mar-2023Targeting RNA Exonuclease XRN1 Potentiates Efficacy of Cancer ImmunotherapyRan, XB; Ding, LW ; Sun, QY ; Yang, H ; Said, JW; Zhentang, L ; Madan, V ; Dakle, P ; Xiao, JF; Loh, X ; Li, Y ; Xu, L ; Xiang, XQ; Wang, LZ; Goh, BC ; Lin, DC; Chng, WJ ; Tan, SY ; Jha, S ; Koeffler, HP